Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-02-27 Gift | 2024-02-28 4:46 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 2,500 | $0 | 51,920 (Direct) | View |
| 2024-02-20 Gift | 2024-02-22 5:08 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 20,000 | $0 | 51,920 (Direct) | View |
| 2024-02-09 Tax Withholding | 2024-02-13 5:37 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 3,533 | $28.8 | 58,920 (Direct) | View |
| 2024-02-09 Exercise | 2024-02-13 5:37 pm | N/A 2031-02-09 | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 11,967 | $0 | 58,920 (Direct) | View |
| 2024-01-06 Tax Withholding | 2024-01-09 9:07 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 6,528 | $20.4 | 355,073 (Direct) | View |
| 2024-01-06 Exercise | 2024-01-09 9:07 pm | N/A 2033-06-19 | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 20,793 | $0 | 355,073 (Direct) | View |
| 2024-01-05 Option Award | 2024-01-09 9:07 pm | N/A 2034-01-05 | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 270,000 | $0 | 355,073 (Direct) | View |
| 2023-07-10 Option Award | 2023-07-12 6:53 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and CEO | 150,000 | $0 | 150,000 (Direct) | View |
| 2023-06-20 Option Award | 2023-06-22 09:13 am | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and COO | 62,380 | $0 | 62,380 (Direct) | View |
| 2023-02-09 Tax Withholding | 2023-02-13 5:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and COO | 4,148 | $4.17 | 48,188 (Direct) | View |
| 2023-02-09 Exercise | 2023-02-13 5:03 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and COO | 11,967 | $0 | 48,188 (Direct) | View |
| 2023-01-06 Option Award | 2023-01-10 5:56 pm | N/A 2033-01-05 | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. President and COO | 124,755 | $0 | 124,755 (Direct) | View |
| 2022-11-01 Tax Withholding | 2022-11-03 08:38 am | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer | 4,479 | $5.42 | 21,402 (Direct) | View |
| 2022-11-01 Exercise | 2022-11-03 08:38 am | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer | 15,258 | $0 | 21,402 (Direct) | View |
| 2022-09-07 Option Award | 2022-09-09 4:19 pm | N/A 2032-09-06 | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer | 65,300 | $0 | 65,300 (Direct) | View |
| 2021-11-01 Option Award(A) | 2022-09-09 4:09 pm | N/A 2031-11-01 | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer | 239,700 | $0 | 239,700 (Direct) | View |
| 2022-06-22 Option Award | 2022-06-24 6:37 pm | N/A 2032-06-22 | Sesen Bio Inc. | SESN | Duker Jay S. Director | 105,000 | $0 | 105,000 (Direct) | View |
| 2022-02-09 Exercise | 2022-02-11 4:41 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer | 4,966 | $0 | 126,557 (Direct) | View |
| 2022-02-09 Option Award | 2022-02-11 4:41 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer | 106,000 | $0 | 126,557 (Direct) | View |
| 2021-11-01 Option Award | 2021-11-03 5:50 pm | 2022-11-01 2031-11-01 | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer | 320,258 | $0 | 320,258 (Direct) | View |
Ownership | 2021-11-03 5:48 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Chief Operating Officer | 0 | $0 | 119,873 (Direct) | View |
| 2021-05-03 Option Award | 2021-05-05 6:18 pm | N/A 2031-05-03 | Sesen Bio Inc. | SESN | Duker Jay S. Director | 92,500 | $0 | 92,500 (Direct) | View |
| 2020-05-06 Option Award | 2020-05-08 5:44 pm | N/A 2030-05-06 | Sesen Bio Inc. | SESN | Duker Jay S. Director | 59,000 | $0 | 59,000 (Direct) | View |
| 2020-02-28 Option Award | 2020-03-03 6:04 pm | 2021-02-28 N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Director | 52,500 | $0 | 52,500 (Direct) | View |
| 2019-06-25 Option Award | 2019-06-27 4:52 pm | 2020-02-21 2029-02-21 | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Director | 40,000 | $0 | 40,000 (Direct) | View |
| 2019-06-21 Exercise | 2019-06-24 4:28 pm | N/A N/A | EyePoint Pharmaceuticals Inc. | EYPT | Duker Jay S. Director | 6,667 | $0 | 44,167 (Direct) | View |
| 2019-06-19 Option Award | 2019-06-21 4:16 pm | N/A 2029-06-18 | Sesen Bio Inc. | SESN | Duker Jay S. Director | 52,500 | $0 | 52,500 (Direct) | View |